Thromboplastin, also known as Tissue Factor, is a protein-phospholipid complex released from damaged cell membranes and initiates the extrinsic system for blood coagulation. This occurs through a specific interaction between thromboplastin and Factor VII, and the complex proceeds to activate Factor X which, in turn, converts prothrombin to thrombin. These steps are coupled in the one-stage prothrombin timetest for assaying the formation of a fibrin clot, as a measure of thromboplastin activity during reconstitution studies.
during reconstitution studies.
In the present study the procedure of Nemerson & Pitlick (1970) was used to delipidate and solubilize the apoprotein component from pig brain. Separation of the two components results in a loss of activity and the restoration of activity to its original value did not require specific phospholipids. The direct binding of a mixture of phospholipids from soya bean to the protein was assisted by micelle formation in 0.25 % (w/v) sodium deoxycholate. Although single or mixed phospholipids of appropriate charge can be used, the protein component of thromboplastin is specific and cannot be replaced by any others.
Since the apoprotein does not have an enzymic role in its activation of Factor VII, the exact nature of this step, which is reversible, is unknown. The present paper therefore reports the structural characterization of thromboplastin by c.d. (circular dichroism) to determine whether its function is related to a particular protein configuration in the presence of those lipids and detergents which restore activity. More specifically we set out to establish whether sodium deoxycholate encouraged binding of lipids by favouring an a-helical, 8-configuration or random-coil form of the apoprotein, compared with sodium taurodeoxycholate, which proved to be an inhibitor.
C.d. spectra were obtained in the near-and far-u.v. regions by the procedure described by Johnson et al. (1974) . Purified apoprotein was measured in a 0.2cm cell in 0 . 0 5~-Tris/HCI buffer, pH7. A mean residue weight of 127 was calculated from amino acid analysis. The data are expressed in the spectra as mean residue ellipticity, [el, in degree cm2. dmol-' plotted against wavelength. The purified apoprotein gave a single band on 5 %-(w/v)-polyacrylamide-gel electrophoresis at pH9.0 (Davis, 1964) . It was found that coagulant activity was restored to an optimum value when 1 mg of the apoprotein was recombined with lOmg of phospholipid dispersed in 0.25 % (w/v) sodium deoxycholate.
This high recombination ratio corresponds to that obtained by Nemerson & Pitlick (1970) for lung-tissue apoprotein and a high value is a function of a pure protein. No activity was restored by lipid dispersed in sodium taurodeoxycholate.
The c.d. spectra over the range 200-250nm in the far-u.v. region of the pure apoprotein alone and in combination with phospholipid and sodium deoxycholate are shown in Fig. l(a) . The apoprotein spectrum shows two negative bands, one centred at 208nm with [@I = -9 . 6~ degree.cm2.dmol-l and the other at 218nm with [@'I = -9.1 x degree-cm2.drnol-'. Comparison of the ellipticity with the graphs of Greenfield & Fasman (1969) suggests that the apoprotein has a low helical content of about 15%. It may, however, contain significant 8-structure (about 40%), the rest being disordered random coil. Sodium deoxycholate, either alone or in combination with phospholipid at the optimum ratio for clotting activity, did not appear to increase the a-helical content and there was a slight decrease in the band at 21 8 nm associated with the &structure. This was in contrast with the observations by Andrews et al. (1976) that lipid-protein interaction in plasma lipoproteins increases the a-helical content to about 60%. When the ratio of protein to lipid was raised above the optimum to 1 :20 (w/v) there was a slight decrease in a-helicity associated with decreased clotting activity. Sodium taurodeoxycholate was inhibitory under all conditions tested, and in its presence the decreased negative ellipticity (Fig. lb) is indicative of a transition from a-helix and 8-structure to random coil. 570th MEETING, CARDIFF Fig. 1. Far-u.v. c.d . spectra (a) The spectra are of thromboplastin apoprotein alone (0.04mg/ml) in 0.025~-Tris/HCl buffer (pH 7.0)/0.25 M-NaCI at 25°C (-), apoprotein (0.04mg/ml)+sodium deoxycholate (2.5 mg/ml) (----), apoprotein (0.04mg/ml)+ soya-bean phospholipids (0.4 mg/ rnl)+sodium deoxycholate (2.5mg/ml) (.-.-) and apoprotein (0.04mg/ml)+soya-bean phospholipids (0.8mg/ml)+sodium deoxycholate (2.5mg/ml) ( a . a ) .
[W] is the mean residue ellipticity. (6) The spectra are of thromboplastin apoprotein (0.045 mg/ml) in buffered saline as in (a) (-), apoprotein (0.045 mg/ml)+sodium deoxycholate (2.5 mg/rnl) (----) and apoprotein (0.045mg/ml)+sodium taurodeoxycholate (2.5 mg/ ml) (.-.-).
Since no marked changes in tertiary structure were observed in the near-u.v. region of the c.d. spectrum we concluded that the a-helical conformation required for lipid binding, as well as any hydrophobic sites for Factor VII in the 8-region, pre-exist in thromboplastin apoprotein. The substitution of deoxycholate by the conjugated tauro form above its critical micellar concentration (1 m) appears to destroy both proteinlipid and protein-protein binding sites. Taurodeoxycholate binds hydrophobically to hydrophobic regions which are more exposed on the surface of the 8-form of a peptide than in the a-helix (Sankar & Doty, 1966) . A similar mechanism has been proposed for the prevention by taurodeoxycholate of the interaction between pancreatic lipase and its colipase (Donner et al., 1976) .
Studies have indicated that the catalytic pocket is largely preexistent in serine proteinases like Factor VII (Neurath & Walsh, 1976) . The generation of a fully active form capable of binding its Factor X substrate could occur following the formation of proteinprotein and protein-lipid linkages with thromboplastin. The apoprotein component of the latter appears less flexible than Factor VII since our studies indicate a stable conformation largely unchanged by lipid.
